Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology China
    Innovative Digital Health Projects to increase the Quality of Life (QoL) of Multiple Myeloma (MM) patients
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy
    2024 RD Global Monitoring anti-TFPI RES
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Call for Independent Medical Education Grant Applications Oncology – Urothelial Carcinoma (UC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Health Services Research to Improve Management of mBC Patients Treated with Tucatinib
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Addressing Multiple Myeloma Gaps in Care for Patients in Latin America
    Release Date:
    Partner: International Myeloma Foundation
    Review Process: Expert Review Panel
    Education Oncology Argentina, Brazil, Colombia, Mexico
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Management of Atopic Dermatitis / Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Pharmacist Education in Biosimilars (Western Europe, Canada, Japan)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Biosimilars in Hematologic Malignancies & Supportive Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    The Burden and Origins of Co-Infections in COVID-19 Pneumonia (Europe)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Advances in Atopic Dermatitis for Advanced Practitioners
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2020 RD US- Next Generation PET Imaging for ATTR-CM
    Release Date:
    Partner: GE Healthcare
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Cardiac Transthyretin Amyloid (ATTR) Fellowship Competitive Grant Program
    Release Date:
    Partner: International Society of Amyloidosis
    Review Process: Expert Review Panel
    Fellowship Rare Disease All
    Management of Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Pfizer and Mayo Clinic/Global Bridges–Providing Access to Learning Resources for Tobacco Dependence Treatment
    Release Date:
    Partner: Mayo Clinic/Global Bridges
    Review Process: Expert Review Panel
    Education Internal Medicine China, Malaysia, Taiwan, Thailand
    4th Quality Improvement initiatives optimizing AF and VTE management in Canada
    Release Date:
    Partner: Bristol-Myers Squibb
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Canada
    2021 Rheumatology Competitive Grant Program
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA